Skip to main content

Advertisement

Open Peer Review Reports for: Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
3 Dec 2015 Submitted Original manuscript
5 Jan 2016 Reviewed Reviewer Report - Chang-Hsien Lu
3 Feb 2016 Author responded Author comments - James Cleary
Resubmission - Version 2
3 Feb 2016 Submitted Manuscript version 2
12 Feb 2016 Reviewed Reviewer Report - Chang-Hsien Lu
15 Feb 2016 Reviewed Reviewer Report - Hideo Baba
4 May 2016 Author responded Author comments - James Cleary
Resubmission - Version 3
4 May 2016 Submitted Manuscript version 3
19 Jun 2016 Author responded Author comments - James Cleary
Resubmission - Version 4
19 Jun 2016 Submitted Manuscript version 4
Publishing
4 Jul 2016 Editorially accepted
13 Jul 2016 Article published 10.1186/s12885-016-2485-9

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement